Lotus Herbal Supplements

Warning LetterOpen

United StatesIssued Jul 6, 2020

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Violations0

Issue DateJul 6, 2020

Product TypeDrugs

StatusOpen

Letter Details

Firm: Lotus Herbal Supplements
Location: United States
FEI Number: N/A
Country: United States
Issue Date: July 06, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, the FDA issued a warning letter to Lotus Herbal Supplements on July 6, 2020, regarding products classified as drugs. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA's drug regulatory authority, though the specific issuing office is not identified in this metadata. To understand the particular compliance issues cited, the complete warning letter would need to be reviewed.

Lotus Herbal Supplements FDA Warning Letter, July 6, 2020